Sorrir Pharmaceuticals Private Limited
About Sorrir Pharmaceuticals Private Limited
Data last updated:
Sorrir Pharmaceuticals Private Limited is a private limited company based in Panvel, Maharashtra, India. It was incorporated on 19 February 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U46497MH2023PTC398172.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shashikant Shivshankar Sharma and Rahmat Nasir Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Panvel, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹80.15 Lakh, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹1.51 Lakh (net margin 1.9%) and EBITDA of ₹2.02 Lakh (EBITDA margin 2.5%).
Company details
Contact details
Sorrir Pharmaceuticals Private Limited's registered office is in Panvel, Maharashtra.
- Registered AddressFl – 103 D – Wing Sec05 Bl – 6, M. Nagar Hill View Nere, Panvel, Maharashtra, India – 410206
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sorrir Pharmaceuticals is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Sorrir Pharmaceuticals Private Limited, buy the company report.
Financials of Sorrir Pharmaceuticals Private Limited
FY 2025 filings availableSorrir Pharmaceuticals Private Limited reported revenue of ₹80.15 Lakh (up 25% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 25% in the latest year. EBITDA rose 6% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2.02 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.51 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2.5% | ||
| Net Profit Margin | 1.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Sorrir Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sorrir Pharmaceuticals Private Limited
Sorrir Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shashikant Shivshankar Sharma | Director | 19 Feb 2023 | 3 Years 8 Months | Current |
| Rahmat Nasir Khan | Director | 19 Feb 2023 | 3 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Sorrir Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sorrir Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sorrir Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sorrir Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Rahmat Nasir Khan was appointed as Director on 19 Feb 2023.
Frequently asked questions
Sorrir Pharmaceuticals is an active private limited company based in Panvel, Maharashtra, India. It was incorporated on 19 February 2023 (3+ years old) and is registered under CIN U46497MH2023PTC398172.
Sorrir Pharmaceuticals has 2 current directors:
- Shashikant Shivshankar Sharma - Director
- Rahmat Nasir Khan - Director
The latest financial statements of Sorrir Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Sorrir Pharmaceuticals is U46497MH2023PTC398172. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sorrir Pharmaceuticals was incorporated on 19 February 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
Rahmat Nasir Khan was appointed as Director on 19 Feb 2023. Shashikant Shivshankar Sharma was appointed as Director on 19 Feb 2023.
The registered office of Sorrir Pharmaceuticals is at Fl – 103 D – Wing Sec05 Bl – 6, M. Nagar Hill View Nere, Panvel, Maharashtra, India – 410206.
Sorrir Pharmaceuticals can be reached at its registered office: Fl – 103 D – Wing Sec05 Bl – 6, M. Nagar Hill View Nere, Panvel, Maharashtra, India – 410206.
Sorrir Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.